Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098211 · ClinicalTrials.gov registry record
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients
A clinical trial, sponsored by Children's Hospital of Orange County.
- Active
- Registry status
- 5
- Enrollment target
NCT04098211 is a clinical trial that is active but no longer recruiting, run by Children's Hospital of Orange County. The registered enrollment target is 5 participants.
The verdict
NCT04098211 is active but no longer recruiting, sponsored by Children's Hospital of Orange County.
- ACTIVE NOT RECRUITING
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on the possible symptoms that patients with atypical neuronal ceroid lipofuscinosis type 2 (also known as aTPP1 or atypical tripeptidyl peptidase deficiency) have and how they change over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04098211
The ClinicalTrials.gov registry entry for NCT04098211 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Orange County, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04098211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04098211 about?
NCT04098211 is a clinical study titled "Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients". The purpose of this study is to gather information on the possible symptoms that patients with atypical neuronal ceroid lipofuscinosis type 2 (also known as aTPP1 or atypical tripeptidyl peptidase deficiency) have and how they change over time.
What is the current status of trial NCT04098211?
This trial is currently active not recruiting. The enrollment target is 5 participants. The study started on 2019-11-01. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT04098211?
This trial is sponsored by Children's Hospital of Orange County, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.